Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Pharmacol Res. 2019 May 6;145:104263. doi: 10.1016/j.phrs.2019.104263

Figure 10. Effect of olaparib on blood, spleen and liver bacterial colony-forming unit (CFU) numbers in young male Balb/c mice subjected to E. coli bacteria in vivo.

Figure 10.

Blood (expressed as CFU/ml), spleen and liver CFUs (expressed as CFU/g) are shown in vehicle-treated mice inoculated with E. coli for 24 hours (“CLP”) and in mice subjected to CLP in the presence of 10 mg/kg olaparib. Data are shown as mean ± SEM of 6 animals for each group.